120 related articles for article (PubMed ID: 9372726)
1. Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations.
Talmon T; Scharf J; Mayer E; Lanir N; Miller B; Brenner B
Am J Ophthalmol; 1997 Nov; 124(5):689-91. PubMed ID: 9372726
[TBL] [Abstract][Full Text] [Related]
2. Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance.
Greven CM; Wall AB
Am J Ophthalmol; 1997 Nov; 124(5):687-9. PubMed ID: 9372725
[TBL] [Abstract][Full Text] [Related]
3. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss.
Kutteh WH; Park VM; Deitcher SR
Fertil Steril; 1999 Jun; 71(6):1048-53. PubMed ID: 10360908
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age.
Rees DC; Liu YT; Cox MJ; Elliott P; Wainscoat JS
Thromb Haemost; 1997 Nov; 78(5):1357-9. PubMed ID: 9408019
[TBL] [Abstract][Full Text] [Related]
5. Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor.
Dhar-Munshi S; Ayliffe WH; Jayne D
Arch Ophthalmol; 1999 Jul; 117(7):971-3. PubMed ID: 10408469
[No Abstract] [Full Text] [Related]
6. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
[TBL] [Abstract][Full Text] [Related]
7. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase.
Rigó J; Nagy B; Fintor L; Tanyi J; Beke A; Karádi I; Papp Z
Hypertens Pregnancy; 2000; 19(2):163-72. PubMed ID: 10877984
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects.
Legnani C; Palareti G; Grauso F; Sassi S; Grossi G; Piazzi S; Bernardi F; Marchetti G; Ferraresi P; Coccheri S
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2924-9. PubMed ID: 9409277
[TBL] [Abstract][Full Text] [Related]
9. Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source.
Salomon O; Huna-Baron R; Moisseiev J; Rosenberg N; Rubovitz A; Steinberg DM; Davidson J; Sela BA; Seligsohn U
Eye (Lond); 2001 Aug; 15(Pt 4):511-4. PubMed ID: 11767028
[TBL] [Abstract][Full Text] [Related]
10. Multiple analysis of three common genetic alterations associated with thrombophilia.
Pecheniuk NM; Marsh NA; Walsh TP
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):183-9. PubMed ID: 10759012
[TBL] [Abstract][Full Text] [Related]
11. Retinal vascular occlusion and deficiencies in the protein C pathway.
Greiner K; Hafner G; Dick B; Peetz D; Prellwitz W; Pfeiffer N
Am J Ophthalmol; 1999 Jul; 128(1):69-74. PubMed ID: 10482096
[TBL] [Abstract][Full Text] [Related]
12. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
[TBL] [Abstract][Full Text] [Related]
13. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G-->A 20210 prothrombin gene and C-->T 677 MTHFR gene mutations.
Hézard N; Cornillet-Lefebvre P; Gillot L; Potron G; Nguyen P
Thromb Haemost; 1998 May; 79(5):1054-5. PubMed ID: 9609246
[No Abstract] [Full Text] [Related]
14. Polycystic ovarian syndrome and thrombophilia.
Tsanadis G; Vartholomatos G; Korkontzelos I; Avgoustatos F; Kakosimos G; Sotiriadis A; Tatsioni A; Eleftheriou A; Lolis D
Hum Reprod; 2002 Feb; 17(2):314-9. PubMed ID: 11821270
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
[TBL] [Abstract][Full Text] [Related]
16. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation.
Dori D; Beiran I; Gelfand Y; Lanir N; Scharf J; Miller B; Brenner B
Am J Ophthalmol; 2000 Jan; 129(1):106-8. PubMed ID: 10653428
[TBL] [Abstract][Full Text] [Related]
17. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.
Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF
Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384
[TBL] [Abstract][Full Text] [Related]
18. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
[TBL] [Abstract][Full Text] [Related]
19. Thermolabile MTHFR genotype and retinal vascular occlusive disease.
Cahill M; Karabatzaki M; Donoghue C; Meleady R; Mynett-Johnson LA; Mooney D; Graham IM; Whitehead AS; Shields DC
Br J Ophthalmol; 2001 Jan; 85(1):88-90. PubMed ID: 11133719
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of factor V Leiden, hyperhomocysteinemia, prothrombin G20210A, and methylene tetrahydrofolate reductase C677T mutations in obstetrical complications].
Verdy E; Berkane N; Magdelaine A; Soubrier F; Uzan S
Ann Biol Clin (Paris); 1999; 57(5):539-44. PubMed ID: 10518055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
